Endometriosis affects up to 10% of women of reproductive age.¹ We are developing a suite of breakthrough tests including HerResolveTM, a non-invasive blood-based test for the detection and confirmation of endometriosis.
Globally, 17.5% of the adult population suffers from infertility.² In the United States, 11% of women³ of reproductive age have experienced fertility problems. Heranova is developing tests and treatments that can improve women’s chances of successfully achieving pregnancy.